Publications / Poster

Liquid biopsy-based detection of triple negative breast cancer at 0.5% tumor content using DNA methylation biomarkers

AACR Special Conference in Cancer Research: Liquid Biopsy

This study discovered novel methylation biomarkers in cell-free DNA that were used to accurately detect triple-negative breast cancer through Harbinger’s assay. High sensitivity at low tumor fractions suggests the potential for improved patient outcomes through early cancer detection.

Read More